Clinical Trial Update: RTA 408 Capsules in Patients With Melanoma - REVEAL [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial update on RTA 408 capsules in melanoma patients, including unresectable stage III and metastatic stage IV disease. The study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• RTA 408

Snippet

Sponsor: Biogen | Conditions: Melanoma, Unresectable (Stage III) Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-06-24